Pain Management in Rheumatoid Arthritis: What’s Adequate-and Appropriate?

Slideshow

Scroll through the slides for a review of the many options available to help reduce pain and improve function.

Recent Videos
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
Related Content
Gout Prevalence to Increase by More Than 70% by 2050

Gout Prevalence to Increase by More Than 70% by 2050

Victoria Johnson
September 20th 2024
Article
Emerging Agents in the Treatment of Rheumatic Diseases

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR;Andrew Sharobeem, DO, FACR;Philip J. Mease, MD
October 2nd 2023
Podcast
Anne Constanze Regierer, MD, head, Registry Research in Rheumatology Research Group, Epidemiology program, German Rheumatism Research Centre Berlin, Germany

Subjective Tolerability Drives PsA Treatment Decisions in Cohort Study

Victoria Johnson
September 19th 2024
Article
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR;Andrew Sharobeem, DO, FACR;John B. Boone, MD, FACR;Madelaine Feldman MD, FACR
August 31st 2023
Podcast
US FDA logo in black over a white background. | Credit: US Food and Drug Administration

FDA Approves Benralizumab for Eosinophilic Granulomatosis with Polyangiitis

Patrick Campbell
September 18th 2024
Article
Patients With PsA and Blue Collar Jobs Have High Rates of Work Disability

Patients With PsA and Blue-Collar Jobs Have High Rates of Work Disability

Victoria Johnson
September 18th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.